Rhumbline Advisers Seagen Inc. Transaction History

Rhumbline Advisers

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 09, 2023	SELL	$191.51 - $216.16 $111,650 - $126,021	-583 Reduced 0.29%	199,453 $42.3 Million
Q2 2023 Aug 08, 2023	BUY	$187.64 - $206.25 $6.02 Million - $6.61 Million	32,071 Added 19.09%	200,036 $38.5 Million
Q1 2023 May 11, 2023	BUY	$127.59 - $203.08 $1.41 Million - $2.24 Million	11,027 Added 7.03%	167,965 $34 Million
Q4 2022 Feb 14, 2023	BUY	$117.37 - $139.17 $1.07 Million - $1.26 Million	9,077 Added 6.14%	156,938 $20.2 Million
Q3 2022 Nov 10, 2022	BUY	$135.27 - $180.11 $622,918 - $829,406	4,605 Added 3.21%	147,861 $20.2 Million

Q2 2022 Aug 11, 2022	BUY	$108.81 - $179.33 $1.74 Million - $2.87 Million	16,009 Added 12.58%	143,256 $25.3 Million
Q1 2022 May 12, 2022	SELL	$119.61 - $157.85 $570,300 - $752,628	-4,768 Reduced 3.61%	127,247 $18.3 Million
Q4 2021 Feb 10, 2022	BUY	$142.57 - $190.86 $687,900 - $920,899	4,825 Added 3.79%	132,015 $20.4 Million
Q3 2021 Nov 12, 2021	SELL	$142.45 - $169.82 $142,592 - $169,989	-1,001 Reduced 0.78%	127,190 $21.6 Million
Q2 2021 Aug 05, 2021	SELL	$135.08 - $161.1 $791,568 - $944,046	-5,860 Reduced 4.37%	128,191 $20.2 Million
Q1 2021 May 06, 2021	SELL	$137.51 - $190.8 $1.59 Million - $2.21 Million	-11,568 Reduced 7.94%	134,051 $18.6 Million
Q4 2020 Feb 10, 2021	SELL	$164.63 - $211.93 $480,225 - $618,199	-2,917 Reduced 1.96%	145,619 $25.5 Million
Q3 2020 Nov 12, 2020	BUY	$145.95 - $195.69 $21.7 Million - $29.1 Million	148,536 New	148,536 $29.1 Million

1.26M

23K

55.2K

Ticker SGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,664,992
Description
Seagen Inc., a biotechnology company, develops and commercializes therapies for the treatment of cancer in the United States and internationally. The company offers ADCETRIS, an antibody-drug conjugate (ADC) for the treatment of patients with Hodgkin lymphoma or CD30-positive T-cell lymphomas; PADCEV, an ADC targeting Nectin-4 for the treatment ...

Get notified when there are updates to the investment portfolio of Rhumbline Advisers, based on Form 13F filings with the SEC.

Stay updated on Rhumbline Advisers with notifications on news.